Search Results - "Pilon D"

A dual band terahertz metamaterial absorber.

Authors: Tao, Hu Bingham, C. M. Pilon, D.

Source: Journal of Physics: D Applied Physics; June 9 2010, Vol. 43 Issue 22, p225102-1-225102-5, 5p

Spin-Induced Optical Conductivity in the Spin-Liquid Candidate Herbertsmithite.

Authors: Pilon, D. V. Lui, C. H. Han, T. -H. et al.

Source: Physical Review Letters. 9/20/2013, Vol. 111 Issue 12, p127401-1-127401-5. 5p.

PMH7 Assessment of Patient out-of-Pocket Costs for Antipsychotic Treatments Among Medicaid Beneficiaries with Schizophrenia.

Authors: Lin, D. Pilon, D. Benson, C. et al.

Source: Value in Health. 2021 Supplement 1, Vol. 24, pS129-S129. 1p.

This result is not displayed to guests.
Login for full access.

PMH17 ECONOMIC BURDEN OF MEDICAID BENEFICIARIES WITH SCHIZOPHRENIA NOT ADHERENT TO ANTIPSYCHOTICS AND WITH SCHIZOPHRENIA RELAPSES.

Authors: Pilon, D. Patel, C.A. Lafeuille, M.H. et al.

Source: Value in Health. 2020 Supplement 1, Vol. 23, pS203-S203. 1p.

Impact of the introduction of newer long-acting reversible contraceptive (LARC) methods on LARC use in a commercially insured population.

Authors: Law, A. Pilon, D. Lynen, R. et al.

Source: Contraception. Oct2015, Vol. 92 Issue 4, p374-375. 2p.

PMD71 - IMPACT OF THE INTRODUCTION OF NEWER LONG ACTING REVERSIBLE CONTRACEPTIVE (LARC) METHODS ON LARC USE IN A COMMERCIALLY INSURED POPULATION.

Authors: Law, A. Pilon, D. Lynen, R. et al.

Source: Value in Health. May2016, Vol. 19 Issue 3, pA309-A309. 1p.

PMH82 - Treatment Patterns In Medicaid Beneficiaries With Schizophrenia Reaching Stabilized Maintenance With Once-Monthly Paliperidone Palmitate Therapy.

Authors: Pilon, D Muser, E Emond, B et al.

Source: Value in Health. May2016, Vol. 19 Issue 3, pA196-A196. 1p.

PDB27 - Glycated Hemoglobin (Hba1c) Control In Patients with Type 2 Diabetes Mellitus (T2dm) Treated with Canagliflozin In a real-world setting.

Authors: Lefebvre, P. Pilon, D. Robitaille, M. et al.

Source: Value in Health. May2015, Vol. 18 Issue 3, pA57-A57. 1p.

Hospital Length Of Stay: Does Rivaroxaban Reduce Inpatient Stay Compared To Warfarin Among Patients With Non-Valvular Atrial Fibrillation?

Authors: Laliberté, F. Pilon, D. Raut, M. et al.

Source: Value in Health. May2014, Vol. 17 Issue 3, pA102-A102. 1p.

Trion-Induced Negative Photoconductivity in Monolayer MoS2.

Authors: Lui, C. H. Frenzel, A. J. Pilon, D. V. et al.

Source: Physical Review Letters. 10/17/2014, Vol. 113 Issue 16, p166801-1-166801-5. 5p.

Observation of a Warped Helical Spin Texture in Bi2Se3 from Circular Dichroism Angle-Resolved Photoemission Spectroscopy.

Authors: Wang, Y. H. Hsieh, D. Pilon, D. et al.

Source: Physical Review Letters. 11/11/2011, Vol. 107 Issue 20, p207602-1-207602-5. 5p.

PMH9 Economic Burden of Major Depressive Disorder with Acute Suicidal Ideation or Behavior in the United States.

Authors: Zhdanava, M. Voelker, J. Pilon, D. et al.

Source: Value in Health. 2021 Supplement 1, Vol. 24, pS129-S130. 2p.

A field of possibilities.

Authors: Pilon, D.

Source: Athletic Management. 1991: Vol. 3 Issue 5. p. 20-22-22.

NEW TECHNIQUES OF COLOR APPLICATION IN THE CARPET INDUSTRY.

Authors: Pilon D.¹ (AUTHOR)

Source: Textile: Canadian Textile Journal / Revue Canadienne du Textile. Jul1980, Vol. 97, p62. 1p.

PMH8 Projecting the Economic Outcomes of Switching Patients with Schizophrenia from Oral Atypical Antipsychotics to Once-Monthly Paliperidone Palmitate and Once-Every-Three-Months Paliperidone Palmitate.

Authors: Lin, D. Morrison, L. Pilon, D. et al.

Source: Value in Health. 2021 Supplement 1, Vol. 24, pS129-S129. 1p.

PMH23 ECONOMIC BURDEN OF SCHIZOPHRENIA AMONG YOUNG ADULTS WITH MEDICAID COVERAGE.

Authors: Lafeuille, M.H. Patel, C.A. Pilon, D. et al.

Source: Value in Health. 2020 Supplement 1, Vol. 23, pS204-S204. 1p.

PDB7 - REAL-WORLD EVALUATION OF WEIGHT LOSS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TREATED WITH CANAGLIFLOZIN - AN ELECTRONIC HEALTH RECORD-BASED STUDY.

Authors: Lefebvre, P. Chow, W. Pilon, D. et al.

Source: Value in Health. May2016, Vol. 19 Issue 3, pA198-A198. 1p.

RWD88 Real-World Economic Burden Pre- and Post-Progression to Metastatic Castration-Resistant Prostate Cancer (mCRPC) and after First-Line mCRPC Therapy Initiation.

Authors: Kaye, D.R Khilfeh, I. Muser, E. et al.

Source: Value in Health. 2023 Supplement, Vol. 26 Issue 6, pS377-S377. 1p.

CO27 Real-World Treatment Response and Persistence Among Black and Non-Black Patients with Metastatic Castration-Sensitive Prostate Cancer Treated with Apalutamide in a Urology Setting.

Authors: Lowentritt, B. Du, S. Rossi, C. et al.

Source: Value in Health. 2023 Supplement, Vol. 26 Issue 6, pS19-S19. 1p.